Tags

Type your tag names separated by a space and hit enter

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

Abstract

OBJECTIVE

To investigate the contribution of biomarkers of glucose homeostasis (adiponectin, glucose, glycated albumin, and insulin levels) and inflammation (high-sensitivity C-reactive protein and lipoprotein-associated phospholipase A(2) levels) to the risk of developing Alzheimer disease (AD) and all-cause dementia.

DESIGN

Prospective cohort study.

SETTING

Dementia-free Framingham Heart Study participants had sera measured for these biomarkers at the 19th biennial examination (1985-1988) and were followed up prospectively for the development of AD and all-cause dementia.

PARTICIPANTS

Eight hundred forty (541 women, median age of 76 years) subjects participated in the study.

MAIN OUTCOME MEASURES

We used sex-pooled and sex-specific multivariable Cox proportional hazards models adjusted for age, education, body mass index, recent change in weight, APOE ε4 allele status, and plasma docosahexaenoic acid levels to determine association of these biomarkers with the development of all-cause dementia and AD.

RESULTS

Over a mean follow-up period of 13 years, 159 persons developed dementia (including 125 with AD). After adjustment for other risk factors, only adiponectin in women was associated with an increased risk of all-cause dementia (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.00-1.66; P=.054) and AD (HR, 1.33; 95% CI, 1.00-1.76; P=.050) per 1-SD increase in adiponectin level. Women with baseline adiponectin values more than the median had a higher risk of all-cause dementia (HR, 1.63; 95% CI, 1.03-2.56; P=.04) and AD (HR, 1.87; 95% CI, 1.13-3.10; P=.01) as compared with those with values less than the median.

CONCLUSION

In women, increased plasma adiponectin levels are an independent risk factor for the development of both all-cause dementia and AD.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA.

    , , , , , , ,

    Source

    Archives of neurology 69:5 2012 May pg 594-600

    MeSH

    1-Alkyl-2-acetylglycerophosphocholine Esterase
    Adiponectin
    Age Factors
    Aged
    Aged, 80 and over
    Alzheimer Disease
    Apolipoproteins E
    Blood Glucose
    C-Reactive Protein
    Chromatography, High Pressure Liquid
    Cohort Studies
    Dementia
    Female
    Fluorometry
    Humans
    Inflammation
    Insulin
    Insulin Resistance
    Male
    Middle Aged
    Peptide Fragments
    Proportional Hazards Models
    Retrospective Studies
    Risk Factors
    Serum Albumin
    Sex Factors

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Research Support, Non-U.S. Gov't
    Research Support, U.S. Gov't, Non-P.H.S.

    Language

    eng

    PubMed ID

    22213409

    Citation

    van Himbergen, Thomas M., et al. "Biomarkers for Insulin Resistance and Inflammation and the Risk for All-cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study." Archives of Neurology, vol. 69, no. 5, 2012, pp. 594-600.
    van Himbergen TM, Beiser AS, Ai M, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch Neurol. 2012;69(5):594-600.
    van Himbergen, T. M., Beiser, A. S., Ai, M., Seshadri, S., Otokozawa, S., Au, R., ... Schaefer, E. J. (2012). Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Archives of Neurology, 69(5), pp. 594-600.
    van Himbergen TM, et al. Biomarkers for Insulin Resistance and Inflammation and the Risk for All-cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study. Arch Neurol. 2012;69(5):594-600. PubMed PMID: 22213409.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. AU - van Himbergen,Thomas M, AU - Beiser,Alexa S, AU - Ai,Masumi, AU - Seshadri,Sudha, AU - Otokozawa,Seiko, AU - Au,Rhoda, AU - Thongtang,Nuntakorn, AU - Wolf,Philip A, AU - Schaefer,Ernst J, PY - 2012/1/4/entrez PY - 2012/1/4/pubmed PY - 2012/12/10/medline SP - 594 EP - 600 JF - Archives of neurology JO - Arch. Neurol. VL - 69 IS - 5 N2 - OBJECTIVE: To investigate the contribution of biomarkers of glucose homeostasis (adiponectin, glucose, glycated albumin, and insulin levels) and inflammation (high-sensitivity C-reactive protein and lipoprotein-associated phospholipase A(2) levels) to the risk of developing Alzheimer disease (AD) and all-cause dementia. DESIGN: Prospective cohort study. SETTING: Dementia-free Framingham Heart Study participants had sera measured for these biomarkers at the 19th biennial examination (1985-1988) and were followed up prospectively for the development of AD and all-cause dementia. PARTICIPANTS: Eight hundred forty (541 women, median age of 76 years) subjects participated in the study. MAIN OUTCOME MEASURES: We used sex-pooled and sex-specific multivariable Cox proportional hazards models adjusted for age, education, body mass index, recent change in weight, APOE ε4 allele status, and plasma docosahexaenoic acid levels to determine association of these biomarkers with the development of all-cause dementia and AD. RESULTS: Over a mean follow-up period of 13 years, 159 persons developed dementia (including 125 with AD). After adjustment for other risk factors, only adiponectin in women was associated with an increased risk of all-cause dementia (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.00-1.66; P=.054) and AD (HR, 1.33; 95% CI, 1.00-1.76; P=.050) per 1-SD increase in adiponectin level. Women with baseline adiponectin values more than the median had a higher risk of all-cause dementia (HR, 1.63; 95% CI, 1.03-2.56; P=.04) and AD (HR, 1.87; 95% CI, 1.13-3.10; P=.01) as compared with those with values less than the median. CONCLUSION: In women, increased plasma adiponectin levels are an independent risk factor for the development of both all-cause dementia and AD. SN - 1538-3687 UR - https://www.unboundmedicine.com/medline/citation/22213409/Biomarkers_for_insulin_resistance_and_inflammation_and_the_risk_for_all_cause_dementia_and_alzheimer_disease:_results_from_the_Framingham_Heart_Study_ L2 - https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/archneurol.2011.670 DB - PRIME DP - Unbound Medicine ER -